Such methodologies may elucidate the mechanistic interactions among Lp(a), atrial remodeling, and thromboembolic risk, and assess whether Lp(a) could significantly improve existing stroke risk stratification models in AF. The gene discussed is LPA; the disease is stroke disorder.